
Claret Capital Raises €575 Million to Back European Tech and Life Sciences Beyond Equity Dilution
European venture debt provider Claret Capital has raised €575 million to finance growth-stage technology and life-sciences companies, offering founders capital without the equity dilution of traditional venture rounds.








